SPOTLIGHT -
PARP Inhibitors and Their Evolving Role in Breast Cancer
Poly(adenosine diphosphate [ADP]–ribose) polymerase (PARP) inhibitors are designed to exploit the “synthetic lethality” concept for cancer therapy.
